506 related articles for article (PubMed ID: 26455500)
1. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
[TBL] [Abstract][Full Text] [Related]
2. PET imaging of α
Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.
Gao Y; Kellar KJ; Yasuda RP; Tran T; Xiao Y; Dannals RF; Horti AG
J Med Chem; 2013 Oct; 56(19):7574-89. PubMed ID: 24050653
[TBL] [Abstract][Full Text] [Related]
4. 18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
Horti AG; Gao Y; Kuwabara H; Wang Y; Abazyan S; Yasuda RP; Tran T; Xiao Y; Sahibzada N; Holt DP; Kellar KJ; Pletnikov MV; Pomper MG; Wong DF; Dannals RF
J Nucl Med; 2014 Apr; 55(4):672-7. PubMed ID: 24556591
[TBL] [Abstract][Full Text] [Related]
5. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
[TBL] [Abstract][Full Text] [Related]
6. Human brain imaging of α7 nAChR with [(18)F]ASEM: a new PET radiotracer for neuropsychiatry and determination of drug occupancy.
Wong DF; Kuwabara H; Pomper M; Holt DP; Brasic JR; George N; Frolov B; Willis W; Gao Y; Valentine H; Nandi A; Gapasin L; Dannals RF; Horti AG
Mol Imaging Biol; 2014 Oct; 16(5):730-8. PubMed ID: 25145965
[TBL] [Abstract][Full Text] [Related]
7. Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.
Wong DF; Kuwabara H; Horti AG; Roberts JM; Nandi A; Cascella N; Brasic J; Weerts EM; Kitzmiller K; Phan JA; Gapasin L; Sawa A; Valentine H; Wand G; Mishra C; George N; McDonald M; Lesniak W; Holt DP; Azad BB; Dannals RF; Kem W; Freedman R; Gjedde A
Int J Neuropsychopharmacol; 2018 Jul; 21(7):656-667. PubMed ID: 29522184
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Characterization of Dibenzothiophene Derivatives [
Donat CK; Hansen HH; Hansen HD; Mease RC; Horti AG; Pomper MG; L'Estrade ET; Herth MM; Peters D; Knudsen GM; Mikkelsen JD
Molecules; 2020 Mar; 25(6):. PubMed ID: 32245032
[TBL] [Abstract][Full Text] [Related]
9. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
Ettrup A; Mikkelsen JD; Lehel S; Madsen J; Nielsen EØ; Palner M; Timmermann DB; Peters D; Knudsen GM
J Nucl Med; 2011 Sep; 52(9):1449-56. PubMed ID: 21828113
[TBL] [Abstract][Full Text] [Related]
10. Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.
Horti AG
Biochem Pharmacol; 2015 Oct; 97(4):566-575. PubMed ID: 26232729
[TBL] [Abstract][Full Text] [Related]
11. High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using
Coughlin JM; Rubin LH; Du Y; Rowe SP; Crawford JL; Rosenthal HB; Frey SM; Marshall ES; Shinehouse LK; Chen A; Speck CL; Wang Y; Lesniak WG; Minn I; Bakker A; Kamath V; Smith GS; Albert MS; Azad BB; Dannals RF; Horti A; Wong DF; Pomper MG
J Nucl Med; 2020 Mar; 61(3):423-426. PubMed ID: 31420499
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
13. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
[TBL] [Abstract][Full Text] [Related]
14. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
16. The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [
Coughlin JM; Du Y; Rosenthal HB; Slania S; Min Koo S; Park A; Solomon G; Vranesic M; Antonsdottir I; Speck CL; Rootes-Murdy K; Lerner A; Rowe SP; Wang Y; Lesniak WG; Minn I; Bakker A; Smith GS; Dannals RF; Kuwabara H; Horti A; Wong DF; Pomper MG
Neuroimage; 2018 Jan; 165():118-124. PubMed ID: 28993233
[TBL] [Abstract][Full Text] [Related]
17. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
18. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
[TBL] [Abstract][Full Text] [Related]
19. Development of
Nag S; Miranda-Azpiazu P; Jia Z; Datta P; Arakawa R; Moein MM; Yang Z; Tu Y; Lemoine L; Ågren H; Nordberg A; Långström B; Halldin C
ACS Chem Neurosci; 2022 Feb; 13(3):352-362. PubMed ID: 35020351
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
